The biopharma company achieved $1 billion in revenue for the first time in its September-ended quarter. More recently, it achieved a more significant milestone when it turned prof ...

Exclusive: OpenEvidence aims to be ‘Disney+’ with new JAMA deal. OpenEvidence this morning announced it has a new multi-year ...

Nuvectis Pharma (NASDAQ:NVCT) stands out in the biotech sector, with a strong presence in the Best Nasdaq Stocks.

ONC certified, Open EMR contains a raft of features ... and secure messaging to patients. AMS Ultra Charts is Ultra Charts from American Medical Software is an EMR solution that manages patient ...

The Official Charts Company has inked a brand new deal with technical support partner Kantar extending their relationship into a fifth decade. The new contract will see the two companies continue ...

Marvel’s “Thunderbolts” and Ryan Coogler’s “Sinners” dominated the North American box office charts again this weekend. Now in their second and fourth weekends respectively ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on BeiGene (ONC – Research Report), with a price target of $334.00. The company’s shares closed yesterday at $249.13.

Question: What are constant pressure charts? Answer: Constant pressure charts like the 500 mb chart shown below may seem obvious to interpret. It has many features similar to what you might see on ...

Check out the latest action across Billboard's dance charts. By Xander Zellner Billboard’s Dance Moves roundup serves as a guide to the biggest movers and shakers across Billboard’s many dance ...

The Official Charts Company’s new annual charts book, The Official Charts & Hits: 2024, hits the book shelves this week. Featuring every Official Singles Chart and Official Albums Chart Top 75 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...